Who Can Use SYNDROS?

SYNDROS (dronabinol) is the First and Only FDA-Approved CII Tetrahydrocannabinol (THC), a liquid cannabinoid.

If you are an adult cancer patient experiencing chemotherapy-induced nausea and vomiting (CINV) or an adult AIDS patient with anorexia associated with weight loss, Syndros may be an option for you.

Many adult patients on antiemetics still experience nausea and vomiting while receiving chemotherapy, 30-50% of adult patients receiving moderately or highly emetogenic chemotherapy continue to experience breakthrough CINV, despite the progressive introduction of antiemetic (anti-nausea) agents.

Many adult patient in the United States with AIDS may experience anorexia associated weight loss, despite the use of highly active antiretroviral therapy, it is estimated that the prevalence of HIV wasting syndrome is between 14% and 38%.

If you experience either of these conditions, it’s important to talk to your doctor.

Talk to your doctor if SYNDROS may be an option for you.

Model, not actual patient.

How Can SYNDROS Help?

If you are an adult cancer patient experiencing CINV or an adult AIDS patient experiencing anorexia associated with weight loss and you feel that SYNDROS may be an option for you, it’s important to speak with your healthcare provider.

Learn more about SYNDROS for chemotherapy-induced nausea and vomiting or anorexia associated with weight loss in adult AIDS patients.